SEC Form 4 · accession 0001209191-16-106791
MEDIVATION, INC. · MDVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mohammad Hirmand
Officer — Interim Chief Medical Officer
Period of report
Mar 4, 2016
Accepted (ET)
Mar 7, 2016 · 8:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Mar 4, 2016 | S | 1,525 | $41.1047 | D | 39,342 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- F2The shares were sold at prices between $41.0981 and $41.115. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Includes 454 shares purchased through the issuer's ESPP.